Heavy‐Atom‐Free Dual‐Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position
ChemMedChem · 2026
DOI: 10.1002/cmdc.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Vladislav Bykusov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Lomonosov Moscow State University, Moscow, Russia. Hauptthemen laut MEDLINE: Prodrugs, Boron Compounds, Photochemotherapy, Photosensitizing Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a clinically approved therapeutic modality with great potential for the treatment of cancers due to its excellent spatiotemporal selectivity and noninvasivenes. A combination of light‐controlled chemotherapy (PACT) and PDT in one molecule has the potential to overcome crucial drawbacks of both Pt‐based chemotherapy and PDT via a synergetic effect. Herein, we report a Pt(IV)‐BODIPY agent for dual light‐controlled chemophotodynamic therapy, a Pt(IV) prodrug with a BODIPY orthogonal dimer in the axial position. The orthogonal arrangement of the fluorophores results in a long‐lived, “heavy‐atom‐free” triplet state of the dimeric fluorophore. The high quantum yield of singlet oxygen for the dimer fluorophore and the Pt(IV) prodrug based on it was confirmed, and the formation of the triplet state was demonstrated by flash photolysis. The excellent photosensitive properties of the Pt(IV) prodrug on SK‐BR‐3 and MCF‐7 tumor cells demonstrate photocontrolled toxicity and potential for the development of dual therapy conjugates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Lomonosov Moscow State University, Moscow, Russia.
- Enikolopov Institute of Synthetic Polymer Materials RAS, Moscow, Russia.
- Department of Bioсhemistry, Petrovsky Medical University, Moscow, Russia.
- N.K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia.
- Frumkin Institute of Physical Chemistry and Electrochemistry Russian Academy of Sciences, Moscow, Russia.
- Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences, Moscow, Russia.
ORCID-Profile: Valerii Mun, Dmitry Bunin, Elena Beloglazkina, Olga Krasnovskaya
Förderung
- Russian Science Foundation
Zitieren
APA
Bykusov, V., Isaeva, Y., Akasov, R., Egorova, T., Mun, V., Bunin, D., Kuzmin, V., Egorov, A., Burtsev, I., Grishin, Y., Rodin, I., Vokuev, M., Beloglazkina, E., & Krasnovskaya, O. (2026). Heavy‐Atom‐Free Dual‐Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position. ChemMedChem. https://doi.org/10.1002/cmdc.70412
Vancouver
Bykusov V, Isaeva Y, Akasov R, Egorova T, Mun V, Bunin D, et al. Heavy‐Atom‐Free Dual‐Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position. ChemMedChem. 2026. doi:10.1002/cmdc.70412
BibTeX
@article{Bykusov2026,
author = {Bykusov, Vladislav and Isaeva, Yulia and Akasov, Roman and Egorova, Tatiana and Mun, Valerii and Bunin, Dmitry and Kuzmin, Vladimir and Egorov, Anton and Burtsev, Ivan and Grishin, Yuri and Rodin, Igor and Vokuev, Mikhail and Beloglazkina, Elena and Krasnovskaya, Olga},
title = {Heavy‐Atom‐Free Dual‐Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70412}
}
EUVIMED